 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/04/2026 |
$34.11 |
$35.27 |
$33.51 |
$34.58 |
448.40K | | 05/05/2026 |
$34.76 |
$35.50 |
$34.33 |
$35.32 |
390.50K | | 05/06/2026 |
$35.09 |
$36.76 |
$35.09 |
$36.51 |
900.90K | | 05/07/2026 |
$37.50 |
$39.58 |
$35.81 |
$39.33 |
913.80K | | 05/08/2026 |
$39.65 |
$40.50 |
$37.61 |
$37.80 |
698.00K |
 |
| Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. Co. commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the U.S.. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed with abuse deterrent properties and uses a technology platform, DETERx. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic. | |
 |

Collegium Pharmaceutical (COLL) has the following price history information. Looking back at COLL historical stock prices for the last five trading days, on May 04, 2026, COLL opened at $34.11, traded as high as $35.27 and as low as $33.51, and closed at $34.58. Trading volume was a total of 448.40K shares. On May 05, 2026, COLL opened at $34.76, traded as high as $35.50 and as low as $34.33, and closed at $35.32. Trading volume was a total of 390.50K shares. On May 06, 2026, COLL opened at $35.09, traded as high as $36.76 and as low as $35.09, and closed at $36.51. Trading volume was a total of 900.90K shares. On May 07, 2026, COLL opened at $37.50, traded as high as $39.58 and as low as $35.81, and closed at $39.33. Trading volume was a total of 913.80K shares. On May 08, 2026, COLL opened at $39.65, traded as high as $40.50 and as low as $37.61, and closed at $37.80. Trading volume was a total of 698.00K shares.
COLL Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Collegium Pharmaceutical shares, starting with a $10,000 purchase of COLL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/11/2016 |
|
| End date: |
05/08/2026 |
|
| Start price/share: |
$15.07 |
|
| End price/share: |
$37.80 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
150.83% |
|
| Average Annual Total Return: |
9.63% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$25,071.76 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 05/04/2026 | $34.58 | | 05/05/2026 | $35.32 | | 05/06/2026 | $36.51 | | 05/07/2026 | $39.33 | | 05/08/2026 | $37.80 |
|
 |